News|Videos|November 17, 2026

Challenges Clear Peanut Labels in 35% of Infants: Rani Maskatia, MD

Fact checked by: Victoria Johnson

Rani Maskatia, MD, discusses ADAPT findings showing 35% of infants with suspected peanut allergy passed oral food challenges, at ACAAI 2026.

More than one-third of infants with a recent peanut reaction and positive allergy testing tolerated peanut during a supervised oral food challenge in Australia's ADAPT peanut oral immunotherapy (OIT) program, findings Zahida "Rani" Maskatia, MD, medical director at Latitude Food Allergy Care, said reinforce the challenge as the diagnostic gold standard.1

Maskatia discussed the findings with HCPLive at the American College of Allergy, Asthma and Immunology (ACAAI) 2026 Annual Scientific Meeting, held November 12-16, 2026, in Phoenix, Arizona. The ADAPT evaluation assessed 1,275 infants younger than 18 months at 10 pediatric public hospitals across 5 Australian states, and 778 underwent a threshold oral food challenge before starting OIT.1,2 Eligible infants had a Consortium for Food Allergy Research grade 1 or 2 reaction to peanut before 12 months of age and a positive sensitization test.3

"So this really emphasizes for us, number one, that allergy testing is imperfect. And also that especially in very, very young children, their immune systems are still developing and they are still adapting. And so it really emphasizes the importance of an accurate diagnosis," Maskatia said.

Overall, 34.8% of challenged infants had a negative challenge and had their peanut allergy label removed, and all reactions, including anaphylaxis, were safely managed.1,3 Among infants who reacted, 97.5% started OIT at a dose guided by their challenge threshold.2 Maskatia said infants often tolerate higher OIT doses and tend to have milder reactions than older children, which can shorten treatment and ease the burden on families.

Maskatia said skin and blood tests rarely produce false negatives but often produce false positives, and infants with a convincing history but low test values may warrant a challenge, since those who tolerate peanut should eat it regularly to prevent allergy. She said the findings should be replicated in the United States and with other allergens, such as cashew, which is less often outgrown. ADAPT will reassess infants with negative challenges at 2 years to determine whether any redevelop peanut allergy.4

Maskatia had no relevant disclosures.

References

  1. Brettig T, McDonald E, et al. An oral food challenge routinely considered for accurate diagnosis of peanut allergy in infants prior to oral immunotherapy: evaluation of the ADAPT peanut oral immunotherapy program. J Allergy Clin Immunol Pract. 2026;14(11):2658-2668.e5. doi:10.1016/j.jaip.2026.08.044
  2. A third of babies have peanut allergy diagnosis removed. National Allergy Centre of Excellence. November 5, 2026. Accessed November 15, 2026. https://www.nace.org.au/knowledge-hub/news-media/2026/a-third-of-babies-have-peanut-allergy-diagnosis-removed/
  3. Oral food challenge before OIT shows 35% of infants thought to be peanut-allergic are not. Healio. November 6, 2026. Accessed November 15, 2026. https://www.healio.com/news/allergy-asthma/20261106/oral-food-challenge-before-oit-shows-35-of-infants-thought-to-be-peanutallergic-are-not
  4. More than a third of infants misdiagnosed with peanut allergy. Medical Republic. Accessed November 15, 2026. https://www.medicalrepublic.com.au/more-than-a-third-of-infants-misdiagnosed-with-peanut-allergy/130988

Related to this article